Sector News

DuPont considers potential $20B sale of biosciences unit – Bloomberg

August 7, 2019
Chemical Value Chain

DuPont (DD +3.8%) is considering unloading its nutrition and biosciences division, and is working with advisers to evaluate options that could include selling or spinning off the business, Bloomberg reports.

The division, which makes food additives and ingredients, could be worth at least $20B as a stand-alone entity, based on the trading multiples of rivals, according to the report.

Logical partners for such a deal are said to include International Flavors & Fragrances (NYSE:IFF), Kerry Group (OTCPK:KRYAY), Givaudan (OTCPK:GVDBF) and Royal DSM.

By: Carl Surran

Source: Seeking Alpha

comments closed

Related News

July 3, 2022

Neste acquires European rights to Alterra’s chemical recycling tech for difficult plastics

Chemical Value Chain

Neste has bought the European rights for Alterra Energy’s liquefaction technology, strengthening its chemical recycling capabilities. Alterra is a US-based company that has developed a thermochemical solution for liquefying difficult-to-recycle plastics.

July 3, 2022

Maria Soler Nunez appointed as Head, Group Operations at Lonza

Chemical Value Chain

Lonza appoints Maria Soler Nunez as Head, Group Operations. Maria joins Lonza from Novartis where she has led the quality organization since 2020. Maria will commence her tenure with Lonza Group on 1 August 2022, succeeding Stefan Stoffel, who is retiring from Lonza.

July 3, 2022

AkzoNobel announces Gregoire Poux-Guillaume as new Chief Executive Officer as of November 1, 2022

Chemical Value Chain

AkzoNobel has announced that Gregoire Poux-Guillaume will become the company’s new Chief Executive Officer (CEO) as of November 1, 2022. He will succeed Thierry Vanlancker, who has been CEO and member of the Board of Management since 2017, and whose term of office is coming to an end.